Brimonidine Tartrate has 8 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Alcohol, Anti-Arrhythmics, Barbiturates. Patients taking Brimonidine Tartrate should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 8
- Moderate
- 8
Moderate (8)
- Brimonidine Tartrate + Alcohol— CNS depressant with potential for additive or potentiating effect when used with brimonidine tartrate ophthalmic solutio…
- Brimonidine Tartrate + Anti-Arrhythmics— Alpha-2 agonists may reduce blood pressure; caution advised when used with anti-hypertensives due to potential additive …
- Brimonidine Tartrate + Barbiturates— CNS depressant with potential for additive or potentiating effect when used with brimonidine tartrate ophthalmic solutio…
- Brimonidine Tartrate + Cardiac Glycosides— Brimonidine tartrate may reduce blood pressure; caution is advised when used with cardiac glycosides due to potential ad…
- Brimonidine Tartrate + Monoamine Oxidase Inhibitors (Maois)— May interfere with brimonidine metabolism and potentially result in increased systemic side effects such as hypotension;…
- Brimonidine Tartrate + Nonselective Beta-Adrenergic Antagonists— Alpha-2 agonists may reduce blood pressure; caution advised when used with beta-blockers due to potential additive hypot…
- Brimonidine Tartrate + Sedatives— CNS depressant with potential for additive or potentiating effect when used with brimonidine tartrate ophthalmic solutio…
- Brimonidine Tartrate + Topical Local Anesthetics— CNS depressant with potential for additive or potentiating effect when used with brimonidine tartrate ophthalmic solutio…